Rosalie Scholtes

DRS.

20182019

Research output per year

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 2 Comment/Letter to the editor
  • 2 Review article
  • 1 Article

Mineralocorticoid Antagonism and Diabetic Kidney Disease

Lytvyn, Y., Godoy, L. C., Scholtes, R. A., van Raalte, D. H. & Cherney, D. Z., 1 Jan 2019, In : Current Diabetes Reports. 19, 1, 4.

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

SGLT2 inhibitors’ interaction with other renoactive drugs in type 2 diabetes patients: still a lot to learn

van Baar, M. J. B., Scholtes, R. A. & van Raalte, D. H., 2019, In : Kidney International. 96, 2, p. 283-286

Research output: Contribution to journalComment/Letter to the editorAcademic

Sodium glucose cotransporter (SGLT)-2 inhibitors: Do we need them for glucose-lowering, for cardiorenal protection or both?

Scholtes, R. A., van Baar, M. J. B., Lytvyn, Y., Bjornstad, P., Nieuwdorp, M., Cherney, D. Z. I. & van Raalte, D. H., 2019, In : Diabetes, Obesity and Metabolism. 21, S2, p. 24-33

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a post hoc analysis

Scholtes, R. A., van Raalte, D. H., Correa-Rotter, R., Toto, R. D., Heerspink, H. J. L., Cain, V., Sjöström, C. D., Sartipy, P. & Stefánsson, B. V., 19 Nov 2019, In : Diabetes, Obesity and Metabolism.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Renal outcomes in CVOTs: keep calm and carry on

Muskiet, M. H. A., van Baar, M. J. B., Scholtes, R. A. & van Raalte, D. H., 1 Sep 2018, In : The Lancet Diabetes and Endocrinology. 6, 9, p. 674-676 3 p.

Research output: Contribution to journalComment/Letter to the editorAcademic